Nano-X Imaging Reports Wider Q1 Non-GAAP Loss
07:41 AM EDT, 05/11/2021 (MT Newswires) -- Nano-X Imaging (NNOX) on Tuesday reported a Q1 non-GAAP loss of $0.15 per share, compared with a year-ago loss of $0.09 per share. The Capital IQ estimate for the quarter was a loss of $0.27 per share.
The medical imaging technology company said it ended the quarter with cash and cash equivalents of $219 million and no debt, according to a news release.
The company said it does not expect to meet its previously announced goal of shipping 1,000 multi-source Nanox units by the first quarter of 2022. This is due to delays with the original third-party supplier of the second-generation high-power ceramic tube, which were compounded by the COVID-19 pandemic, the company said.
Nanox is currently working with two alternative tube suppliers for the multi-source system.
The company said it expects to reach the target during 2022 if the multi-source Nanox.ARC is approved by the Food and Drug Administration and authorized by other similar regulatory agencies.
Price: 22.15, Change: -4.03, Percent Change: -15.39